June 13, 2008 - MEDRAD signed a distribution and co-marketing partnership agreement with PETNET Solutions, a fully owned subsidiary of Siemens Medical Solutions, enabling healthcare providers to inject Fluorodeoxyglucose (FDG) for positron emission tomography/computed tomography (PET/CT) imaging procedures in a new way.
MEDRAD’s PET infusion system, Intego, is designed to automatically extract a patient dose from a multidose vial and deliver it directly to the patient. The system is mobile and includes dosimetry, shielding and a touchscreen interface.
PETNET Solutions has agreed to provide FDG to customers throughout its cyclotron-based radiopharmacy network in multidose vials and specially designed vial shields, aiming to allow for easy integration with MEDRAD’s new system.
MEDRAD will show the system at the annual Society of Nuclear Medicine (SNM) meeting in New Orleans, Louisiana, on June 13-16.
For more information: www. medrad.com
August 17, 2023 
